EX-FILING FEES 2 tm2317530d1_ex-filingfees.htm EX-FILING FEES

 

Exhibit 107

 

CALCULATION OF FILING FEE TABLE

 

424(b)(5)

(Form Type)

 

Iovance Biotherapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

    Security
Type		  

Title of Each Class
of
Securities

to be Registered

   Fee
Calculation
Rule		  

Amount to
be

Registered(1)

  

Proposed
Maximum

Offering
Price Per

Share

  

Maximum

Aggregate
Offering

Price

  

Fee

Rate

  

Amount of

Registration

Fee(2)

Fees to be Paid

   Equity   Common stock, par value $0.000041666 per share  

Rule 457(o) and Rule 457(r)

   —   —   $450,000,000   $0.00011020   $49,590
Fees Previously Paid   —   —   —   —   —   —   —   —
    Total Offering Amounts   —   $450,000,000   —   $49,590
    Total Fees Previously Paid   —   —   —   $—
    Total Fee Offsets   —   —   —   $—
    Net Fee Due   —   —   —   $49,590

 

(1) Consists of shares to be issued pursuant to that certain Open Market Sales AgreementSM, or the Sales Agreement, dated June 16, 2023, between Iovance Biotherapeutics, Inc. and Jefferies LLC.

 

(2) Calculated in accordance with Rule 457(o) and Rule 457(r) under the Securities Act of 1933, as amended. Represents payment of registration fees previously deferred in connection with the Registration Statement on Form S-3ASR (Registration No. 333-272718).